Differential Efficacy of Targeted Monoclonal Antibodies in Left-Sided Colon and Rectal Metastatic Cancers.
Clinical colorectal cancer（2023）
摘要
Efficacies of anti-EGFR and BEV therapies may differ between patients with L and RE.
更多查看译文
关键词
Tumor location,Bevacizumab,Anti-EGFR antibody,Overall survival,Progression-free survival
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要